Page last updated: 2024-10-21

3-methoxytyrosine and Developmental Disabilities

3-methoxytyrosine has been researched along with Developmental Disabilities in 1 studies

Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Research Excerpts

ExcerptRelevanceReference
"Chronic bilirubin encephalopathy, characterized clinically by extrapyramidal movement abnormalities, vertical gaze abnormalities, and hearing loss, results from neuronal injury after marked hyperbilirubinemia in term and preterm infants."1.33Clinical (video) findings and cerebrospinal fluid neurotransmitters in 2 children with severe chronic bilirubin encephalopathy, including a former preterm infant without marked hyperbilirubinemia VIDEO. ( Gilbert, DL; Merhar, SL, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merhar, SL1
Gilbert, DL1

Other Studies

1 other study available for 3-methoxytyrosine and Developmental Disabilities

ArticleYear
Clinical (video) findings and cerebrospinal fluid neurotransmitters in 2 children with severe chronic bilirubin encephalopathy, including a former preterm infant without marked hyperbilirubinemia VIDEO.
    Pediatrics, 2005, Volume: 116, Issue:5

    Topics: Child; Developmental Disabilities; Female; Follow-Up Studies; Globus Pallidus; Homovanillic Acid; Hu

2005